Responses
Regular and young investigator award abstracts
Immune-stimulants and immune modulators
565 A novel long-acting interleukin-7 agonist, NT-I7, increases cytotoxic CD8+ T cells and enhances survival in mouse glioma models
Compose a Response to This Article
Other responses
No responses have been published for this article.